Recent Articles
How One-Stop Antibody Customizat...
What Technical Support Is Requir...
What Does Antibody Customization...
Dual-Defect Nitrogen-Rich Carbon Nitride-Based Heterostructural Nanocatalyst:...
In the field of malignant bone tumor treatment, the efficacy of immunotherapy is often limited by issues such as low tumor immunogenicity, insufficient immune infiltration, and an immunosuppressive microenvironment. A...
Dual-Defect Nitrogen-Rich Carbon Nitride-Based Heterostructural Nanocatalyst:...
In the field of malignant bone tumor treatment, the efficacy of immunotherapy is often limited by issues such as low tumor immunogenicity, insufficient immune infiltration, and an immunosuppressive microenvironment. A...
Read More
Bile Acid Receptor FXR Regulating Intestinal Epithelial Ferroptosis
Neonatal Necrotizing Enterocolitis (NEC) is a common life-threatening intestinal emergency in preterm infants. The incidence rate of NEC in very low birth weight infants worldwide is approximately 7%, and the...
Bile Acid Receptor FXR Regulating Intestinal Epithelial Ferroptosis
Neonatal Necrotizing Enterocolitis (NEC) is a common life-threatening intestinal emergency in preterm infants. The incidence rate of NEC in very low birth weight infants worldwide is approximately 7%, and the...
Read More
How Does CCR8+Treg Targeted Therapy Overcome PD1 Resistance?
Recently, Journal of Thoracic Oncology (IF 20.8) published a groundbreaking study on lung cancer immunotherapy titled "Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in...
How Does CCR8+Treg Targeted Therapy Overcome PD1 Resistance?
Recently, Journal of Thoracic Oncology (IF 20.8) published a groundbreaking study on lung cancer immunotherapy titled "Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in...
Read More
Absin IHC Kit Facilitates Key Discoveries in Osteosarcoma Cisplatin Resistanc...
In the field of cancer treatment, osteosarcoma, as the most common primary malignant bone tumor in children and adolescents, has long been limited by cisplatin (DDP) resistance in its treatment....
Absin IHC Kit Facilitates Key Discoveries in Osteosarcoma Cisplatin Resistanc...
In the field of cancer treatment, osteosarcoma, as the most common primary malignant bone tumor in children and adolescents, has long been limited by cisplatin (DDP) resistance in its treatment....
Read More
Lung Cancer Prevention and Treatment: Absin Empowers the Development of Inhal...
As a malignant tumor with both high global incidence and mortality rates, lung cancer has long been a key focus in the field of medical research. Recently, a study titled A...
Lung Cancer Prevention and Treatment: Absin Empowers the Development of Inhal...
As a malignant tumor with both high global incidence and mortality rates, lung cancer has long been a key focus in the field of medical research. Recently, a study titled A...
Read More
Breaking the Bottleneck in Glioblastoma Research: Absin Facilitates the Disco...
Glioblastoma (GBM), as the most aggressive primary brain tumor, has long been a major challenge in the medical field. Recently, a groundbreaking study titled Infiltrating Plasma Cells Maintain Glioblastoma Stem Cells...
Breaking the Bottleneck in Glioblastoma Research: Absin Facilitates the Disco...
Glioblastoma (GBM), as the most aggressive primary brain tumor, has long been a major challenge in the medical field. Recently, a groundbreaking study titled Infiltrating Plasma Cells Maintain Glioblastoma Stem Cells...
Read More